Lode Gold Resources Inc. (TSXV: LOD) (OTCQB: SBMIF) (‘Lode Gold ‘ or the ‘Company’) is pleased to announce its wholly-owned subsidiary, (‘1475039 B.C. Ltd.’ or ‘Gold Orogen’) has entered into a non-binding Letter of Intent …
Investing
-
-
Investing
Constellation to Revive Three Mile Island, Sell Power to Microsoft for AI Data Centers
by adminConstellation Energy (NASDAQ:CEG) plans to revive Three Mile Island (TMI) Unit 1 under a 20 year power purchase agreement with Microsoft (NASDAQ:MSFT) announced on Friday (September 20). According to the company, the deal will bring …
-
Investing
E25’s High-Purity Manganese Project Selected for US$166M Grant Under U.S. DoE Grant Program
by adminElement 25 Limited (E25 or Company) (ASX: E25; OTCQX: ELMTF) is pleased to announce it has been selected for award negotiations for a US$166 million grant from the U.S. Department of Energy (DoE) under the …
-
-
Investing
Continued Excellent Results from Jasper Hills with Initial Fish Deposit Assays up to 45 g/t Gold
by adminBrightstar Resources Limited (ASX: BTR) (Brightstar) is pleased to announce initial results from the Reverse Circulation (RC) drilling at the Fish deposit, part of the 293koz Au Jasper Hills Gold Project; with additional results from …
-
Jindalee Lithium Limited (Jindalee, the Company) advised that it had lodged applications for non-dilutive grant funding with both the Department of Defense (DoD) and the Department of Energy (DoE) (Battery Manufacturing and Recycling Grant)1. Application …
-
Description The securities of Nordic Nickel Limited (‘NNL’) will be placed in trading halt at the request of NNL, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt …
-
ChemX Materials (ASX:CMX) (ChemX or the Company), an Australian high purity critical materials company and 100%-owner of the HiPurA® patented process to produce High Purity Alumina (HPA) ispleased to announce it has received notice of …
-
Investing
Tumour Response in Sixth Patient Triggers Additional Recruitment in Pancreatic Cancer Trial
by adminAmplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce that the Company’s Phase 2a clinical trial investigating narmafotinib in the treatment of advanced pancreatic cancer (the ACCENT trial) has achieved the …
-
Commodities giant BHP (ASX:BHP,NYSE:BHP,LSE:BHP) announced on Wednesday (September 18) that it will partner with the Meewasin Valley Authority on efforts to conserve the Meewasin Valley. Located in Saskatchewan, Canada, the Meewasin Valley is one of …